Atlas Trials

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Clinical trial NCT00425425 · UNKNOWN

Trial details

NCT number
NCT00425425
Sponsor
Technical University of Munich
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2006-07-01
Primary completion
2010-05-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.